Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1429 clinical trials
Promoting Co-Parenting and Reducing Hazardous Drinking in New Families

This study aims to understand if a parenting program that helps couples learn to parent as a team and maintain a healthy lifestyle, such as maintaining safer levels of alcohol use, promotes parent and child health and well-being.

hazardous drinking
heavy drinking
  • 0 views
  • 05 Aug, 2020
The Effect of Preemptive Levator Ani Injections on Pain After Pelvic Reconstructive Surgery

Patients undergoing vaginal pelvic reconstructive surgery for pelvic organ prolapse (POP) under general anesthesia will be randomized to receive bilateral trans-vaginal pelvic floor muscle injections with bupivacaine or no injection (standard of care) as a part of their surgical pain control

prolapse
anaesthesia
analgesia
anesthesia
bupivacaine
  • 0 views
  • 16 Feb, 2024
  • 1 location
Dose Escalation of DF6002 in Patients With Advanced Solid Tumors and Expansion in Selected Indications

This study is a Phase 1/2, open-label, dose-escalation study with a consecutive parallel-group efficacy expansion study, designed to determine the safety, tolerability, PK, pharmacodynamics, and preliminary anti-tumor activity of DF6002 as monotherapy and in combination with pembrolizumab.

gastric cancer
esophageal carcinoma
prostate cancer
immunostimulant
platinum-based chemotherapy
  • 0 views
  • 05 Aug, 2020
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

Radiation therapy, such as stereotactic body radiation therapy, uses special equipment to position a patient and deliver radiation to tumors with high precision.

neutrophil count
atezolizumab
monoclonal antibodies
ct scan
stereotactic body radiation
  • 0 views
  • 16 Feb, 2024
  • 22 locations
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation

All international guidelines recommend 6-monthly ultrasound surveillance for patients at risk for liver cancer (hepatocellular carcinoma or HCC), such as patients with cirrhosis. The aim of surveillance is to detect HCC at an early stage when it is still potentially curable. Currently only 4 out of 10 HCCs are detected …

fibroscan
platelet count
hepatocellular carcinoma
ascites
cirrhosis
  • 0 views
  • 16 Feb, 2024
  • 10 locations
A Randomized Controlled Study on the Treatment of Sacral Canal Cysts With Sacral Canal Reinforcement

The subject will treat 68 patients with symptomatic sacral canal cysts as the research object, and adopt a randomized controlled research method, respectively, using two methods of reinforcement and reconstruction of the nerve root sleeve, sacroplasty and nerve root sleeve plasty, and observed the operation of the patient Complications, preoperative …

  • 0 views
  • 05 Aug, 2020
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

lenalidomide
monoclonal antibodies
cell transplantation
measurable disease
refractory multiple myeloma
  • 0 views
  • 04 Dec, 2020
  • 8 locations
Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease

To investigate the safety and efficacy of an orally administered dose of TW-012R in patients with Alzheimer's disease bearing PSEN1 (presenilin 1) mutations (PSEN1-AD), using a placebo group as a control. In addition, long-term safety will be examined in an open-label extension trial.

dementia
mini-mental state examination
psychiatric disorder
alzheimer's disease
  • 0 views
  • 05 Aug, 2020
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

This is a Phase II treatment, non-randomized, open label clinical trial to study the efficacy of the Cetuximab when administered as single agent in recurrent/ metastatic head and neck squamous cell carcinoma after the failure or intolerance of immuno-oncology or immuno-oncology combined with chemotherapy.

cancer of the head
carcinoma
metastatic head and neck squamous cell cancer
squamous cell carcinoma of head and neck
measurable disease
  • 0 views
  • 05 Aug, 2020
Firefighters Accessing Care for Trauma: A Clinical Case Series of Distance NET for PTSD/I Symptoms

To test the efficacy of the intervention, participants will complete self-report questionnaires about PTSD/I and other mental health symptoms pre- and post-intervention as well as two- and six-months following intervention completion. Participants will also complete an open-ended interview at the end of the intervention to assess feasibility and participant satisfaction.

post-traumatic stress disorder
stress disorders
exposure therapy
traumatic stress disorder
  • 0 views
  • 16 Feb, 2024
  • 1 location